Kura Oncology KURA Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
Based on trailing twelve months.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's interest coverage?
- Kura Oncology (KURA) reported interest coverage of -216.7× in Q1 2026.
- How has Kura Oncology's interest coverage changed year-over-year?
- Kura Oncology's interest coverage decreased by 70.8% year-over-year, from -126.9× to -216.7×.
- What is the long-term trend for Kura Oncology's interest coverage?
- Over 3 years (2022 to 2025), Kura Oncology's interest coverage has grown at a -31.0% compound annual growth rate (CAGR), from -610.8× to -200.8×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.